DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo


company name or ticker

Daniel Loeb Comments on Intrexon Corporation

Is This the Top for Intrexon (XON)? - Tale of the Tape

5 Unbelievable (but Real) Technologies Made Possible by Synthetic Biology

The synthetic biology industry has erupted in recent years. The technological breakthroughs can touch numerous industries, from health care to marijuana production.

Intrexon Moves Up In Market Cap Rank, Passing Newfield Exploration

5 of Last Week's Biggest Winners

These five stocks posted double-digit percentage gains this past week.

Intrexon (XON) in Focus: Stock Moves 8.4% Higher - Tale of the Tape

A Bulletproof Dividend Growth Portfolio For 2014

Daniel Loeb Underperforms for Year: Two Top Stocks Gain, Two Yet to Move

Daniel Loeb Lags S&P But Top New Stocks Advance

This Engineered Salmon Could Double World Production: Should You Fear Frankenfish?

An engineered species of Atlantic salmon could double world aquaculture production, which stands at 230,000 metric tons per year, while offering substantial environmental benefits. What would it mean for consumers if Intrexon and AquaBounty Technologies gain regulatory approval from the U.S. Food and Drug Administration in 2014? A regulatory nod could notch a big win for synthetic biology in addition to pioneering technologies from Amyris and Solazyme.